COMMUNIQUÉS West-GlobeNewswire

Altimmune Announces $25 million Registered Direct Offering
08/10/2018
GAITHERSBURG, Md., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced it has entered into a purchase agreement with several institutional [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
08/10/2018
Villepinte (France), le 08 octobre 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 sur [...]
Teladoc Health to Announce Third Quarter 2018 Financial Results
08/10/2018
PURCHASE, NY, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will release third quarter 2018 results on Thursday, November 1, 2018, after [...]
Sarepta Therapeutics Enters into Long-term Strategic Manufacturing Partnership with Paragon Bioservices, Greatly Enhancing its Commercial Capacity for Future Gene Therapies
08/10/2018
-- Partnership significantly expands commercial capacity for Sarepta’s micro-dystrophin gene therapy program, as well as bolsters the Company’s clinical and commercial capacity for its other pipeline programs -- [...]
Letter to Shareholders from Curt Fairbrother, CEO October 8, 2018
08/10/2018
CORONA, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Dear Shareholders: I’m pleased to tell you that our application to FINRA has been approved and they have formally changed both our business name and stock symbol. We are [...]
Golden Leaf Holdings Announces New Green Apple Flavor CBD Infused Fruit Chews
08/10/2018
PORTLAND, Ore., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
Adamas Presents Final Results from the Two-Year, Phase 3 Open-Label Study of GOCOVRI™ in Parkinson’s Disease Patients with Dyskinesia
08/10/2018
GOCOVRI was generally well tolerated and the safety profile was consistent with previously reported data for up to two years Results show a comparable 35% reduction from baseline in dyskinesia and OFF was achieved [...]
International Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical Trial
08/10/2018
CARLSBAD, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
Cybrexa Therapeutics Appoints Keely Zipp as Vice President of Marketing
08/10/2018
Adds oncology marketing and strategy experience from Incyte Corporation and GlaxoSmithKline NEW HAVEN, Conn., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an early-stage biotechnology company developing a new [...]
BrainsWay Announces First Shipments of Deep Transcranial Magnetic Stimulation Helmets for the Treatment of Obsessive-Compulsive Disorder
08/10/2018
Twenty sites across the U.S. are the first to receive the BrainsWay Deep transcranial magnetic stimulation system (Deep TMS) for obsessive-compulsive disorder (OCD) HACKENSACK, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- [...]
CLS Holdings USA, Inc. Announces up to US$40 Million Brokered Private Placement
08/10/2018
This is not an offer for sale, or solicitation of an offer to buy, nor may there be any sale in the United States or to, or for the account or benefit of, any U.S. Person (as defined in Regulation S under the U.S. [...]
Allakos Presents Data from its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting
08/10/2018
SAN CARLOS, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Allakos Inc. (NASDAQ:ALLK), a clinical stage biotechnology company focused on the development of antibodies for the treatment of eosinophil and mast cell related [...]
Soleno Therapeutics Presents Clinical Data on DCCR at 2018 Foundation for Prader-Willi Research Annual Conference
08/10/2018
Oral presentation on DCCR’s mechanism of action in treating hyperphagia Poster presentation on DCCR’s safety profile and implications for PWS Phase III study design REDWOOD CITY, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE [...]
CDx Diagnostics to Present New WATS3D Data Confirming Crypt Dysplasia as a Risk Factor for Esophageal Cancer in Patients With Barrett’s Esophagus
08/10/2018
- Data Presented at ACG 2018 Presidential Plenary Session Underscores the Value of Using WATS 3D to Ensure Accurate Risk Stratification of BE Patients to Reduce Esophageal Cancer Deaths - SUFFERN, N.Y., Oct. 08, 2018 ( [...]
Cambrex Invests c.$3 Million to Upgrade Generic API Manufacturing Facilities at Milan, Italy Site
08/10/2018
EAST RUTHERFORD, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage [...]
Inovio Successfully Develops First DNA-Encoded Monoclonal Antibody (dMAb™) Checkpoint Inhibitor and Demonstrates Tumor Shrinkage in Preclinical Studies
08/10/2018
Advancement highlighted in prestigious AACR journal Cancer Research PLYMOUTH MEETING, Pa., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today the successful animal testing of DNA [...]
Novan Expands Nitric Oxide Dermatology Business Partnership with Sato in Japan
08/10/2018
Expanded license agreement adds SB206 for the treatment of viral skin infections Novan to receive upfront cash consideration of approximately 1.25 billion JPY (~$11.0 million), payable over the next 12 months Milestone [...]
Cocrystal Pharma Announces Clinical Trial Agreement for Investigator-Initiated Phase 2a Study in Hong Kong of CC-31244 for Ultra-Short Treatment of Hepatitis C Virus
08/10/2018
- Humanity & Health Research Centre to conduct Phase 2a study evaluating CC-31244 for the treatment of hepatitis C - Asia market represents one of the largest hepatitis C virus carrier populations in the world [...]
Public Company Becomes Newest Entrant In Alarm Industry; NuLife Expands from Life Sciences to Life Safety
08/10/2018
NEWPORT BEACH, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- NuLife Sciences, Inc . (OTCQB: “NULF”) announced today that it has successfully closed its previously announced merger with two Louisiana-based electronic [...]

Pages